nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—Mitomycin—stomach cancer	0.107	0.187	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0561	0.0982	CbGbCtD
Midazolam—CYP3A7—Irinotecan—stomach cancer	0.0561	0.0982	CbGbCtD
Midazolam—CYP2B6—Irinotecan—stomach cancer	0.0535	0.0936	CbGbCtD
Midazolam—CYP3A5—Irinotecan—stomach cancer	0.0421	0.0737	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0411	0.072	CbGbCtD
Midazolam—CYP3A7—Docetaxel—stomach cancer	0.0411	0.072	CbGbCtD
Midazolam—CYP3A5—Docetaxel—stomach cancer	0.0309	0.054	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—stomach cancer	0.0292	0.0511	CbGbCtD
Midazolam—ABCB1—Irinotecan—stomach cancer	0.0274	0.048	CbGbCtD
Midazolam—ABCB1—Docetaxel—stomach cancer	0.0201	0.0352	CbGbCtD
Midazolam—CYP3A4—Irinotecan—stomach cancer	0.0164	0.0287	CbGbCtD
Midazolam—ABCB1—Doxorubicin—stomach cancer	0.015	0.0262	CbGbCtD
Midazolam—ABCB1—Methotrexate—stomach cancer	0.0145	0.0254	CbGbCtD
Midazolam—CYP3A4—Docetaxel—stomach cancer	0.012	0.0211	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—stomach cancer	0.00897	0.0157	CbGbCtD
Midazolam—UGT1A4—hematopoietic system—stomach cancer	0.00131	0.0896	CbGeAlD
Midazolam—UGT1A4—digestive system—stomach cancer	0.000912	0.0623	CbGeAlD
Midazolam—CYP4B1—digestive system—stomach cancer	0.000901	0.0615	CbGeAlD
Midazolam—UGT1A4—endocrine gland—stomach cancer	0.000754	0.0515	CbGeAlD
Midazolam—UGT1A4—liver—stomach cancer	0.00068	0.0464	CbGeAlD
Midazolam—CYP3A7—endocrine gland—stomach cancer	0.000525	0.0359	CbGeAlD
Midazolam—CYP4B1—lymph node—stomach cancer	0.000514	0.0351	CbGeAlD
Midazolam—CYP3A7—liver—stomach cancer	0.000474	0.0324	CbGeAlD
Midazolam—GABRA3—endocrine gland—stomach cancer	0.000433	0.0296	CbGeAlD
Midazolam—Hypotension—Fluorouracil—stomach cancer	0.000418	0.00157	CcSEcCtD
Midazolam—Ataxia—Epirubicin—stomach cancer	0.000417	0.00157	CcSEcCtD
Midazolam—Dyspnoea—Irinotecan—stomach cancer	0.000416	0.00157	CcSEcCtD
Midazolam—Somnolence—Irinotecan—stomach cancer	0.000415	0.00156	CcSEcCtD
Midazolam—GABRR2—lymph node—stomach cancer	0.000414	0.0283	CbGeAlD
Midazolam—Eye disorder—Capecitabine—stomach cancer	0.000411	0.00155	CcSEcCtD
Midazolam—Dyspepsia—Irinotecan—stomach cancer	0.000411	0.00155	CcSEcCtD
Midazolam—Immune system disorder—Docetaxel—stomach cancer	0.00041	0.00154	CcSEcCtD
Midazolam—Diplopia—Doxorubicin—stomach cancer	0.00041	0.00154	CcSEcCtD
Midazolam—Osteoarthritis—Doxorubicin—stomach cancer	0.00041	0.00154	CcSEcCtD
Midazolam—Mediastinal disorder—Docetaxel—stomach cancer	0.00041	0.00154	CcSEcCtD
Midazolam—Cardiac disorder—Capecitabine—stomach cancer	0.000408	0.00154	CcSEcCtD
Midazolam—Chills—Docetaxel—stomach cancer	0.000408	0.00153	CcSEcCtD
Midazolam—Affect lability—Doxorubicin—stomach cancer	0.000404	0.00152	CcSEcCtD
Midazolam—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000403	0.00152	CcSEcCtD
Midazolam—CYP3A7-CYP3A51P—liver—stomach cancer	0.000403	0.0275	CbGeAlD
Midazolam—Fatigue—Irinotecan—stomach cancer	0.000403	0.00151	CcSEcCtD
Midazolam—Paraesthesia—Fluorouracil—stomach cancer	0.000402	0.00151	CcSEcCtD
Midazolam—Constipation—Irinotecan—stomach cancer	0.000399	0.0015	CcSEcCtD
Midazolam—Pain—Irinotecan—stomach cancer	0.000399	0.0015	CcSEcCtD
Midazolam—Dyspnoea—Fluorouracil—stomach cancer	0.000399	0.0015	CcSEcCtD
Midazolam—Mental disorder—Docetaxel—stomach cancer	0.000398	0.0015	CcSEcCtD
Midazolam—Somnolence—Fluorouracil—stomach cancer	0.000398	0.0015	CcSEcCtD
Midazolam—Immune system disorder—Capecitabine—stomach cancer	0.000397	0.00149	CcSEcCtD
Midazolam—Mediastinal disorder—Capecitabine—stomach cancer	0.000397	0.00149	CcSEcCtD
Midazolam—Nasopharyngitis—Epirubicin—stomach cancer	0.000396	0.00149	CcSEcCtD
Midazolam—Erythema—Docetaxel—stomach cancer	0.000396	0.00149	CcSEcCtD
Midazolam—Chills—Capecitabine—stomach cancer	0.000395	0.00149	CcSEcCtD
Midazolam—Dyspepsia—Fluorouracil—stomach cancer	0.000394	0.00148	CcSEcCtD
Midazolam—Muscular weakness—Epirubicin—stomach cancer	0.000391	0.00147	CcSEcCtD
Midazolam—Cardiac arrest—Doxorubicin—stomach cancer	0.00039	0.00147	CcSEcCtD
Midazolam—Mood swings—Doxorubicin—stomach cancer	0.000388	0.00146	CcSEcCtD
Midazolam—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000386	0.00145	CcSEcCtD
Midazolam—Ataxia—Doxorubicin—stomach cancer	0.000385	0.00145	CcSEcCtD
Midazolam—Mental disorder—Capecitabine—stomach cancer	0.000385	0.00145	CcSEcCtD
Midazolam—Feeling abnormal—Irinotecan—stomach cancer	0.000385	0.00145	CcSEcCtD
Midazolam—GABRB3—pancreas—stomach cancer	0.000384	0.0262	CbGeAlD
Midazolam—Erythema—Capecitabine—stomach cancer	0.000383	0.00144	CcSEcCtD
Midazolam—Pain—Fluorouracil—stomach cancer	0.000383	0.00144	CcSEcCtD
Midazolam—Feeling abnormal—Fluorouracil—stomach cancer	0.000369	0.00139	CcSEcCtD
Midazolam—Nasopharyngitis—Doxorubicin—stomach cancer	0.000367	0.00138	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—stomach cancer	0.000365	0.00137	CcSEcCtD
Midazolam—Depression—Methotrexate—stomach cancer	0.000364	0.00137	CcSEcCtD
Midazolam—Muscular weakness—Doxorubicin—stomach cancer	0.000362	0.00136	CcSEcCtD
Midazolam—Vision blurred—Capecitabine—stomach cancer	0.000361	0.00136	CcSEcCtD
Midazolam—Tremor—Capecitabine—stomach cancer	0.000359	0.00135	CcSEcCtD
Midazolam—Urticaria—Fluorouracil—stomach cancer	0.000355	0.00134	CcSEcCtD
Midazolam—Syncope—Docetaxel—stomach cancer	0.000355	0.00133	CcSEcCtD
Midazolam—Cough—Docetaxel—stomach cancer	0.000345	0.0013	CcSEcCtD
Midazolam—Vertigo—Capecitabine—stomach cancer	0.000344	0.00129	CcSEcCtD
Midazolam—Hypersensitivity—Irinotecan—stomach cancer	0.000344	0.00129	CcSEcCtD
Midazolam—Syncope—Capecitabine—stomach cancer	0.000343	0.00129	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—stomach cancer	0.000341	0.00128	CcSEcCtD
Midazolam—Asthenia—Irinotecan—stomach cancer	0.000335	0.00126	CcSEcCtD
Midazolam—Neuropathy peripheral—Epirubicin—stomach cancer	0.000335	0.00126	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000334	0.00126	CcSEcCtD
Midazolam—Cough—Capecitabine—stomach cancer	0.000334	0.00126	CcSEcCtD
Midazolam—Hypersensitivity—Fluorouracil—stomach cancer	0.00033	0.00124	CcSEcCtD
Midazolam—Dry mouth—Docetaxel—stomach cancer	0.000329	0.00124	CcSEcCtD
Midazolam—Confusional state—Docetaxel—stomach cancer	0.000326	0.00122	CcSEcCtD
Midazolam—Anxiety—Capecitabine—stomach cancer	0.000325	0.00122	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000324	0.00122	CcSEcCtD
Midazolam—Anaphylactic shock—Docetaxel—stomach cancer	0.000323	0.00121	CcSEcCtD
Midazolam—CYP3A5—hematopoietic system—stomach cancer	0.000322	0.022	CbGeAlD
Midazolam—ABCB1—blood vessel—stomach cancer	0.000321	0.0219	CbGeAlD
Midazolam—CYP2B6—hematopoietic system—stomach cancer	0.00032	0.0219	CbGeAlD
Midazolam—Dry mouth—Capecitabine—stomach cancer	0.000319	0.0012	CcSEcCtD
Midazolam—Shock—Docetaxel—stomach cancer	0.000318	0.00119	CcSEcCtD
Midazolam—Nervous system disorder—Docetaxel—stomach cancer	0.000317	0.00119	CcSEcCtD
Midazolam—Pruritus—Fluorouracil—stomach cancer	0.000316	0.00119	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—stomach cancer	0.000316	0.00119	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—stomach cancer	0.000316	0.00119	CcSEcCtD
Midazolam—Confusional state—Capecitabine—stomach cancer	0.000315	0.00119	CcSEcCtD
Midazolam—Tachycardia—Docetaxel—stomach cancer	0.000315	0.00119	CcSEcCtD
Midazolam—Skin disorder—Docetaxel—stomach cancer	0.000314	0.00118	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—stomach cancer	0.000312	0.00117	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—stomach cancer	0.00031	0.00116	CcSEcCtD
Midazolam—Dizziness—Irinotecan—stomach cancer	0.000309	0.00116	CcSEcCtD
Midazolam—Shock—Capecitabine—stomach cancer	0.000308	0.00116	CcSEcCtD
Midazolam—Nervous system disorder—Capecitabine—stomach cancer	0.000307	0.00115	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—stomach cancer	0.000306	0.00115	CcSEcCtD
Midazolam—Tachycardia—Capecitabine—stomach cancer	0.000305	0.00115	CcSEcCtD
Midazolam—SLC22A1—endocrine gland—stomach cancer	0.000305	0.0208	CbGeAlD
Midazolam—Cardiac disorder—Methotrexate—stomach cancer	0.000304	0.00114	CcSEcCtD
Midazolam—Skin disorder—Capecitabine—stomach cancer	0.000304	0.00114	CcSEcCtD
Midazolam—Hypotension—Docetaxel—stomach cancer	0.000302	0.00113	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—stomach cancer	0.000301	0.00113	CcSEcCtD
Midazolam—CYP2E1—hematopoietic system—stomach cancer	0.0003	0.0205	CbGeAlD
Midazolam—Vomiting—Irinotecan—stomach cancer	0.000297	0.00112	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—stomach cancer	0.000296	0.00111	CcSEcCtD
Midazolam—Dizziness—Fluorouracil—stomach cancer	0.000296	0.00111	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—stomach cancer	0.000295	0.00111	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—stomach cancer	0.000295	0.00111	CcSEcCtD
Midazolam—Rash—Irinotecan—stomach cancer	0.000294	0.00111	CcSEcCtD
Midazolam—Dermatitis—Irinotecan—stomach cancer	0.000294	0.00111	CcSEcCtD
Midazolam—Chills—Methotrexate—stomach cancer	0.000294	0.00111	CcSEcCtD
Midazolam—Headache—Irinotecan—stomach cancer	0.000293	0.0011	CcSEcCtD
Midazolam—Hypotension—Capecitabine—stomach cancer	0.000292	0.0011	CcSEcCtD
Midazolam—Paraesthesia—Docetaxel—stomach cancer	0.00029	0.00109	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—stomach cancer	0.000289	0.00109	CcSEcCtD
Midazolam—Dyspnoea—Docetaxel—stomach cancer	0.000288	0.00108	CcSEcCtD
Midazolam—Somnolence—Docetaxel—stomach cancer	0.000287	0.00108	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—stomach cancer	0.000287	0.00108	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—stomach cancer	0.000286	0.00108	CcSEcCtD
Midazolam—Erythema—Methotrexate—stomach cancer	0.000285	0.00107	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—stomach cancer	0.000284	0.00107	CcSEcCtD
Midazolam—Vomiting—Fluorouracil—stomach cancer	0.000284	0.00107	CcSEcCtD
Midazolam—Dyspepsia—Docetaxel—stomach cancer	0.000284	0.00107	CcSEcCtD
Midazolam—Rash—Fluorouracil—stomach cancer	0.000282	0.00106	CcSEcCtD
Midazolam—Dermatitis—Fluorouracil—stomach cancer	0.000282	0.00106	CcSEcCtD
Midazolam—Paraesthesia—Capecitabine—stomach cancer	0.000281	0.00106	CcSEcCtD
Midazolam—Headache—Fluorouracil—stomach cancer	0.00028	0.00105	CcSEcCtD
Midazolam—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000279	0.00105	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—stomach cancer	0.000279	0.00105	CcSEcCtD
Midazolam—Dyspnoea—Capecitabine—stomach cancer	0.000279	0.00105	CcSEcCtD
Midazolam—Fatigue—Docetaxel—stomach cancer	0.000278	0.00105	CcSEcCtD
Midazolam—Nausea—Irinotecan—stomach cancer	0.000277	0.00104	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—stomach cancer	0.000277	0.00104	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—stomach cancer	0.000276	0.00104	CcSEcCtD
Midazolam—Pain—Docetaxel—stomach cancer	0.000276	0.00104	CcSEcCtD
Midazolam—Constipation—Docetaxel—stomach cancer	0.000276	0.00104	CcSEcCtD
Midazolam—Dyspepsia—Capecitabine—stomach cancer	0.000275	0.00104	CcSEcCtD
Midazolam—Chills—Epirubicin—stomach cancer	0.000275	0.00103	CcSEcCtD
Midazolam—SLC22A1—liver—stomach cancer	0.000275	0.0188	CbGeAlD
Midazolam—Visual impairment—Doxorubicin—stomach cancer	0.000273	0.00103	CcSEcCtD
Midazolam—GABRB3—endocrine gland—stomach cancer	0.000271	0.0185	CbGeAlD
Midazolam—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00027	0.00102	CcSEcCtD
Midazolam—Fatigue—Capecitabine—stomach cancer	0.000269	0.00101	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—stomach cancer	0.000269	0.00101	CcSEcCtD
Midazolam—Mental disorder—Epirubicin—stomach cancer	0.000269	0.00101	CcSEcCtD
Midazolam—Pain—Capecitabine—stomach cancer	0.000267	0.00101	CcSEcCtD
Midazolam—Constipation—Capecitabine—stomach cancer	0.000267	0.00101	CcSEcCtD
Midazolam—Erythema—Epirubicin—stomach cancer	0.000267	0.001	CcSEcCtD
Midazolam—Feeling abnormal—Docetaxel—stomach cancer	0.000266	0.001	CcSEcCtD
Midazolam—Nausea—Fluorouracil—stomach cancer	0.000266	0.000999	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—stomach cancer	0.000265	0.000997	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—stomach cancer	0.000263	0.00099	CcSEcCtD
Midazolam—CYP3A5—pancreas—stomach cancer	0.000262	0.0179	CbGeAlD
Midazolam—Tension—Epirubicin—stomach cancer	0.000262	0.000985	CcSEcCtD
Midazolam—Nervousness—Epirubicin—stomach cancer	0.000259	0.000975	CcSEcCtD
Midazolam—Feeling abnormal—Capecitabine—stomach cancer	0.000258	0.000969	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—stomach cancer	0.000256	0.000964	CcSEcCtD
Midazolam—Vertigo—Methotrexate—stomach cancer	0.000256	0.000964	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—stomach cancer	0.000256	0.000961	CcSEcCtD
Midazolam—Chills—Doxorubicin—stomach cancer	0.000254	0.000957	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—stomach cancer	0.000251	0.000946	CcSEcCtD
Midazolam—Cough—Methotrexate—stomach cancer	0.000249	0.000936	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—stomach cancer	0.000248	0.000935	CcSEcCtD
Midazolam—Urticaria—Capecitabine—stomach cancer	0.000248	0.000934	CcSEcCtD
Midazolam—Erythema—Doxorubicin—stomach cancer	0.000247	0.000929	CcSEcCtD
Midazolam—Agitation—Epirubicin—stomach cancer	0.000245	0.000922	CcSEcCtD
Midazolam—GABRB3—liver—stomach cancer	0.000244	0.0167	CbGeAlD
Midazolam—Tension—Doxorubicin—stomach cancer	0.000242	0.000911	CcSEcCtD
Midazolam—CYP3A4—hematopoietic system—stomach cancer	0.000241	0.0165	CbGeAlD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000241	0.000907	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—stomach cancer	0.00024	0.000902	CcSEcCtD
Midazolam—Vertigo—Epirubicin—stomach cancer	0.00024	0.000902	CcSEcCtD
Midazolam—Syncope—Epirubicin—stomach cancer	0.000239	0.0009	CcSEcCtD
Midazolam—Hypersensitivity—Docetaxel—stomach cancer	0.000238	0.000895	CcSEcCtD
Midazolam—Confusional state—Methotrexate—stomach cancer	0.000235	0.000883	CcSEcCtD
Midazolam—Cough—Epirubicin—stomach cancer	0.000233	0.000876	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—stomach cancer	0.000233	0.000875	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—stomach cancer	0.000233	0.000875	CcSEcCtD
Midazolam—Asthenia—Docetaxel—stomach cancer	0.000232	0.000871	CcSEcCtD
Midazolam—Hypersensitivity—Capecitabine—stomach cancer	0.00023	0.000866	CcSEcCtD
Midazolam—Pruritus—Docetaxel—stomach cancer	0.000228	0.000859	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—stomach cancer	0.000228	0.000858	CcSEcCtD
Midazolam—Agitation—Doxorubicin—stomach cancer	0.000227	0.000853	CcSEcCtD
Midazolam—Anxiety—Epirubicin—stomach cancer	0.000226	0.000852	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—stomach cancer	0.000226	0.00085	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000226	0.000849	CcSEcCtD
Midazolam—CYP2B6—lymphoid tissue—stomach cancer	0.000225	0.0154	CbGeAlD
Midazolam—Asthenia—Capecitabine—stomach cancer	0.000224	0.000844	CcSEcCtD
Midazolam—CYP3A5—digestive system—stomach cancer	0.000224	0.0153	CbGeAlD
Midazolam—GABRA2—lymph node—stomach cancer	0.000223	0.0152	CbGeAlD
Midazolam—CYP2B6—digestive system—stomach cancer	0.000222	0.0152	CbGeAlD
Midazolam—Dry mouth—Epirubicin—stomach cancer	0.000222	0.000836	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—stomach cancer	0.000222	0.000834	CcSEcCtD
Midazolam—Syncope—Doxorubicin—stomach cancer	0.000221	0.000833	CcSEcCtD
Midazolam—Pruritus—Capecitabine—stomach cancer	0.000221	0.000832	CcSEcCtD
Midazolam—GABRE—lymph node—stomach cancer	0.000221	0.0151	CbGeAlD
Midazolam—Confusional state—Epirubicin—stomach cancer	0.00022	0.000826	CcSEcCtD
Midazolam—Anaphylactic shock—Epirubicin—stomach cancer	0.000218	0.000819	CcSEcCtD
Midazolam—Hypotension—Methotrexate—stomach cancer	0.000217	0.000818	CcSEcCtD
Midazolam—Cough—Doxorubicin—stomach cancer	0.000215	0.00081	CcSEcCtD
Midazolam—Shock—Epirubicin—stomach cancer	0.000214	0.000806	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—stomach cancer	0.000214	0.000803	CcSEcCtD
Midazolam—Dizziness—Docetaxel—stomach cancer	0.000213	0.000803	CcSEcCtD
Midazolam—Tachycardia—Epirubicin—stomach cancer	0.000213	0.000799	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—stomach cancer	0.000212	0.000796	CcSEcCtD
Midazolam—CYP2E1—lymphoid tissue—stomach cancer	0.000211	0.0144	CbGeAlD
Midazolam—Anxiety—Doxorubicin—stomach cancer	0.000209	0.000788	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—stomach cancer	0.000209	0.000786	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000209	0.000785	CcSEcCtD
Midazolam—CYP2E1—digestive system—stomach cancer	0.000209	0.0143	CbGeAlD
Midazolam—Dyspnoea—Methotrexate—stomach cancer	0.000207	0.00078	CcSEcCtD
Midazolam—Somnolence—Methotrexate—stomach cancer	0.000207	0.000778	CcSEcCtD
Midazolam—Dizziness—Capecitabine—stomach cancer	0.000207	0.000778	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—stomach cancer	0.000206	0.000773	CcSEcCtD
Midazolam—Vomiting—Docetaxel—stomach cancer	0.000205	0.000772	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—stomach cancer	0.000205	0.000771	CcSEcCtD
Midazolam—Rash—Docetaxel—stomach cancer	0.000204	0.000766	CcSEcCtD
Midazolam—Hypotension—Epirubicin—stomach cancer	0.000203	0.000765	CcSEcCtD
Midazolam—Dermatitis—Docetaxel—stomach cancer	0.000203	0.000765	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—stomach cancer	0.000203	0.000764	CcSEcCtD
Midazolam—Headache—Docetaxel—stomach cancer	0.000202	0.000761	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—stomach cancer	0.000201	0.000758	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000201	0.000756	CcSEcCtD
Midazolam—Fatigue—Methotrexate—stomach cancer	0.000201	0.000755	CcSEcCtD
Midazolam—Pain—Methotrexate—stomach cancer	0.000199	0.000749	CcSEcCtD
Midazolam—Vomiting—Capecitabine—stomach cancer	0.000199	0.000748	CcSEcCtD
Midazolam—Shock—Doxorubicin—stomach cancer	0.000198	0.000746	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—stomach cancer	0.000198	0.000743	CcSEcCtD
Midazolam—Rash—Capecitabine—stomach cancer	0.000197	0.000741	CcSEcCtD
Midazolam—Dermatitis—Capecitabine—stomach cancer	0.000197	0.000741	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—stomach cancer	0.000197	0.00074	CcSEcCtD
Midazolam—Headache—Capecitabine—stomach cancer	0.000196	0.000737	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—stomach cancer	0.000196	0.000736	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—stomach cancer	0.000196	0.000736	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—stomach cancer	0.000194	0.00073	CcSEcCtD
Midazolam—Somnolence—Epirubicin—stomach cancer	0.000194	0.000728	CcSEcCtD
Midazolam—Nausea—Docetaxel—stomach cancer	0.000192	0.000721	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—stomach cancer	0.000192	0.000721	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—stomach cancer	0.000192	0.000721	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—stomach cancer	0.000188	0.000708	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000188	0.000707	CcSEcCtD
Midazolam—Fatigue—Epirubicin—stomach cancer	0.000188	0.000706	CcSEcCtD
Midazolam—Constipation—Epirubicin—stomach cancer	0.000186	0.0007	CcSEcCtD
Midazolam—Pain—Epirubicin—stomach cancer	0.000186	0.0007	CcSEcCtD
Midazolam—Nausea—Capecitabine—stomach cancer	0.000186	0.000698	CcSEcCtD
Midazolam—CYP3A5—endocrine gland—stomach cancer	0.000185	0.0126	CbGeAlD
Midazolam—Urticaria—Methotrexate—stomach cancer	0.000185	0.000695	CcSEcCtD
Midazolam—CYP2B6—endocrine gland—stomach cancer	0.000184	0.0126	CbGeAlD
Midazolam—Paraesthesia—Doxorubicin—stomach cancer	0.000181	0.000681	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—stomach cancer	0.00018	0.000676	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—stomach cancer	0.000179	0.000675	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—stomach cancer	0.000179	0.000674	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—stomach cancer	0.000177	0.000667	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000174	0.000654	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—stomach cancer	0.000174	0.000653	CcSEcCtD
Midazolam—Urticaria—Epirubicin—stomach cancer	0.000173	0.000651	CcSEcCtD
Midazolam—CYP2E1—endocrine gland—stomach cancer	0.000172	0.0118	CbGeAlD
Midazolam—Constipation—Doxorubicin—stomach cancer	0.000172	0.000648	CcSEcCtD
Midazolam—Pain—Doxorubicin—stomach cancer	0.000172	0.000648	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—stomach cancer	0.000171	0.000645	CcSEcCtD
Midazolam—ABCB1—hematopoietic system—stomach cancer	0.000171	0.0117	CbGeAlD
Midazolam—CYP3A4—digestive system—stomach cancer	0.000168	0.0115	CbGeAlD
Midazolam—Asthenia—Methotrexate—stomach cancer	0.000167	0.000628	CcSEcCtD
Midazolam—CYP3A5—liver—stomach cancer	0.000167	0.0114	CbGeAlD
Midazolam—Feeling abnormal—Doxorubicin—stomach cancer	0.000166	0.000625	CcSEcCtD
Midazolam—CYP2B6—liver—stomach cancer	0.000166	0.0113	CbGeAlD
Midazolam—Pruritus—Methotrexate—stomach cancer	0.000165	0.000619	CcSEcCtD
Midazolam—Hypersensitivity—Epirubicin—stomach cancer	0.00016	0.000604	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—stomach cancer	0.00016	0.000602	CcSEcCtD
Midazolam—ABCB1—epithelium—stomach cancer	0.000156	0.0107	CbGeAlD
Midazolam—Asthenia—Epirubicin—stomach cancer	0.000156	0.000588	CcSEcCtD
Midazolam—CYP2E1—liver—stomach cancer	0.000155	0.0106	CbGeAlD
Midazolam—Pruritus—Epirubicin—stomach cancer	0.000154	0.00058	CcSEcCtD
Midazolam—Dizziness—Methotrexate—stomach cancer	0.000154	0.000579	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—stomach cancer	0.000148	0.000558	CcSEcCtD
Midazolam—Vomiting—Methotrexate—stomach cancer	0.000148	0.000557	CcSEcCtD
Midazolam—Rash—Methotrexate—stomach cancer	0.000147	0.000552	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—stomach cancer	0.000147	0.000551	CcSEcCtD
Midazolam—Headache—Methotrexate—stomach cancer	0.000146	0.000548	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—stomach cancer	0.000145	0.000544	CcSEcCtD
Midazolam—Dizziness—Epirubicin—stomach cancer	0.000144	0.000542	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—stomach cancer	0.000143	0.000536	CcSEcCtD
Midazolam—ABCB1—pancreas—stomach cancer	0.000139	0.00951	CbGeAlD
Midazolam—CYP3A4—endocrine gland—stomach cancer	0.000139	0.00948	CbGeAlD
Midazolam—Vomiting—Epirubicin—stomach cancer	0.000138	0.000521	CcSEcCtD
Midazolam—Nausea—Methotrexate—stomach cancer	0.000138	0.00052	CcSEcCtD
Midazolam—Rash—Epirubicin—stomach cancer	0.000137	0.000516	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—stomach cancer	0.000137	0.000516	CcSEcCtD
Midazolam—Headache—Epirubicin—stomach cancer	0.000136	0.000513	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—stomach cancer	0.000133	0.000501	CcSEcCtD
Midazolam—Nausea—Epirubicin—stomach cancer	0.000129	0.000487	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—stomach cancer	0.000128	0.000482	CcSEcCtD
Midazolam—Rash—Doxorubicin—stomach cancer	0.000127	0.000478	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—stomach cancer	0.000127	0.000477	CcSEcCtD
Midazolam—Headache—Doxorubicin—stomach cancer	0.000126	0.000475	CcSEcCtD
Midazolam—CYP3A4—liver—stomach cancer	0.000125	0.00855	CbGeAlD
Midazolam—ABCB1—lymphoid tissue—stomach cancer	0.00012	0.00822	CbGeAlD
Midazolam—Nausea—Doxorubicin—stomach cancer	0.00012	0.00045	CcSEcCtD
Midazolam—ABCB1—digestive system—stomach cancer	0.000119	0.00812	CbGeAlD
Midazolam—ABCB1—bone marrow—stomach cancer	0.00011	0.00749	CbGeAlD
Midazolam—ABCB1—endocrine gland—stomach cancer	9.82e-05	0.00671	CbGeAlD
Midazolam—ABCB1—liver—stomach cancer	8.86e-05	0.00605	CbGeAlD
Midazolam—ABCB1—lymph node—stomach cancer	6.79e-05	0.00464	CbGeAlD
Midazolam—GABRB2—Neuronal System—HRAS—stomach cancer	2.67e-05	0.00018	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MAPK1—stomach cancer	2.66e-05	0.000179	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ECHS1—stomach cancer	2.66e-05	0.000179	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PDHA1—stomach cancer	2.66e-05	0.000179	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ECHS1—stomach cancer	2.65e-05	0.000179	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PDHA1—stomach cancer	2.65e-05	0.000179	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FBP1—stomach cancer	2.64e-05	0.000178	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NDUFA2—stomach cancer	2.64e-05	0.000178	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CA1—stomach cancer	2.64e-05	0.000178	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CKB—stomach cancer	2.64e-05	0.000178	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ALB—stomach cancer	2.64e-05	0.000178	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.6e-05	0.000176	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CAV1—stomach cancer	2.6e-05	0.000175	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—HRAS—stomach cancer	2.59e-05	0.000175	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—APOA1—stomach cancer	2.59e-05	0.000175	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALOX5—stomach cancer	2.59e-05	0.000175	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—FADS1—stomach cancer	2.55e-05	0.000172	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TYMP—stomach cancer	2.55e-05	0.000172	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—HRAS—stomach cancer	2.55e-05	0.000172	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.55e-05	0.000172	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—DPYD—stomach cancer	2.54e-05	0.000172	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GMPR2—stomach cancer	2.52e-05	0.00017	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—HRAS—stomach cancer	2.5e-05	0.000169	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TYMP—stomach cancer	2.5e-05	0.000169	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—FADS1—stomach cancer	2.5e-05	0.000169	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—FADS1—stomach cancer	2.49e-05	0.000168	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TYMP—stomach cancer	2.49e-05	0.000168	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.49e-05	0.000168	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—HRAS—stomach cancer	2.49e-05	0.000168	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLIN2—stomach cancer	2.48e-05	0.000167	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—HRAS—stomach cancer	2.44e-05	0.000165	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTT1—stomach cancer	2.42e-05	0.000163	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CA2—stomach cancer	2.41e-05	0.000163	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.41e-05	0.000163	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP2A6—stomach cancer	2.39e-05	0.000161	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SREBF2—stomach cancer	2.39e-05	0.000161	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—HRAS—stomach cancer	2.38e-05	0.000161	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—RORA—stomach cancer	2.36e-05	0.000159	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NT5E—stomach cancer	2.35e-05	0.000159	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PGAM1—stomach cancer	2.35e-05	0.000159	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SREBF2—stomach cancer	2.34e-05	0.000158	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SREBF2—stomach cancer	2.33e-05	0.000157	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKR1C3—stomach cancer	2.32e-05	0.000157	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—RORA—stomach cancer	2.31e-05	0.000156	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—IDH3B—stomach cancer	2.31e-05	0.000156	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SUCLG1—stomach cancer	2.31e-05	0.000156	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—RORA—stomach cancer	2.31e-05	0.000156	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ALB—stomach cancer	2.3e-05	0.000155	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2.3e-05	0.000155	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	2.3e-05	0.000155	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PPARG—stomach cancer	2.28e-05	0.000154	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MAPK1—stomach cancer	2.27e-05	0.000154	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ENO1—stomach cancer	2.26e-05	0.000153	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTT1—stomach cancer	2.25e-05	0.000152	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDH7A1—stomach cancer	2.24e-05	0.000151	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLCE1—stomach cancer	2.24e-05	0.000151	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	2.22e-05	0.00015	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2A6—stomach cancer	2.22e-05	0.00015	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALDOB—stomach cancer	2.21e-05	0.000149	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	2.17e-05	0.000147	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALDOB—stomach cancer	2.16e-05	0.000146	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKR1C3—stomach cancer	2.16e-05	0.000146	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALDOB—stomach cancer	2.16e-05	0.000146	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—UMPS—stomach cancer	2.15e-05	0.000145	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.14e-05	0.000145	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.14e-05	0.000145	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—HRAS—stomach cancer	2.13e-05	0.000144	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ENO1—stomach cancer	2.11e-05	0.000142	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALOX5—stomach cancer	2.05e-05	0.000139	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ALB—stomach cancer	2.05e-05	0.000139	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—DPYD—stomach cancer	2.02e-05	0.000136	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALOX5—stomach cancer	2.01e-05	0.000136	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CD44—stomach cancer	2.01e-05	0.000136	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALOX5—stomach cancer	2.01e-05	0.000136	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.01e-05	0.000135	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PDHA1—stomach cancer	2e-05	0.000135	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ECHS1—stomach cancer	2e-05	0.000135	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—DPYD—stomach cancer	1.98e-05	0.000134	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—DPYD—stomach cancer	1.98e-05	0.000133	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ALB—stomach cancer	1.97e-05	0.000133	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NOS3—stomach cancer	1.96e-05	0.000133	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.92e-05	0.00013	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BLVRB—stomach cancer	1.91e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PGLS—stomach cancer	1.91e-05	0.000129	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.9e-05	0.000128	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TYMP—stomach cancer	1.88e-05	0.000127	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FADS1—stomach cancer	1.88e-05	0.000127	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CD44—stomach cancer	1.87e-05	0.000126	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.84e-05	0.000125	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—HRAS—stomach cancer	1.83e-05	0.000123	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.82e-05	0.000123	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.8e-05	0.000122	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.8e-05	0.000122	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—stomach cancer	1.8e-05	0.000121	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTT1—stomach cancer	1.79e-05	0.000121	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—stomach cancer	1.77e-05	0.000119	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2A6—stomach cancer	1.77e-05	0.000119	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SREBF2—stomach cancer	1.76e-05	0.000119	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTT1—stomach cancer	1.75e-05	0.000118	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTT1—stomach cancer	1.75e-05	0.000118	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—RORA—stomach cancer	1.74e-05	0.000117	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP2A6—stomach cancer	1.73e-05	0.000117	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.73e-05	0.000117	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKR1C3—stomach cancer	1.72e-05	0.000116	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.72e-05	0.000116	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPP2R1A—stomach cancer	1.71e-05	0.000115	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.7e-05	0.000115	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKR1C3—stomach cancer	1.68e-05	0.000114	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKR1C3—stomach cancer	1.68e-05	0.000113	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTP1—stomach cancer	1.68e-05	0.000113	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ENO1—stomach cancer	1.67e-05	0.000113	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HMOX1—stomach cancer	1.65e-05	0.000112	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ENO1—stomach cancer	1.64e-05	0.000111	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ENO1—stomach cancer	1.64e-05	0.000111	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDOB—stomach cancer	1.63e-05	0.00011	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CKB—stomach cancer	1.63e-05	0.00011	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA1—stomach cancer	1.63e-05	0.00011	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FBP1—stomach cancer	1.63e-05	0.00011	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.63e-05	0.00011	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPP2R1A—stomach cancer	1.59e-05	0.000107	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.57e-05	0.000106	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTP1—stomach cancer	1.56e-05	0.000105	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TYMS—stomach cancer	1.56e-05	0.000105	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTM1—stomach cancer	1.54e-05	0.000104	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HMOX1—stomach cancer	1.54e-05	0.000104	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLIN2—stomach cancer	1.53e-05	0.000103	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALOX5—stomach cancer	1.52e-05	0.000102	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.52e-05	0.000102	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—DPYD—stomach cancer	1.49e-05	0.000101	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA2—stomach cancer	1.49e-05	0.0001	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CD44—stomach cancer	1.49e-05	0.0001	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.46e-05	9.84e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CD44—stomach cancer	1.45e-05	9.82e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CD44—stomach cancer	1.45e-05	9.8e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TYMS—stomach cancer	1.45e-05	9.78e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PGAM1—stomach cancer	1.45e-05	9.78e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NT5E—stomach cancer	1.45e-05	9.78e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ERCC2—stomach cancer	1.45e-05	9.77e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—stomach cancer	1.43e-05	9.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLCE1—stomach cancer	1.38e-05	9.33e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.38e-05	9.33e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MTHFR—stomach cancer	1.36e-05	9.18e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ERCC2—stomach cancer	1.35e-05	9.09e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—UMPS—stomach cancer	1.33e-05	8.95e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTT1—stomach cancer	1.32e-05	8.9e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2A6—stomach cancer	1.3e-05	8.8e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKR1C3—stomach cancer	1.27e-05	8.56e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MTHFR—stomach cancer	1.27e-05	8.55e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPP2R1A—stomach cancer	1.26e-05	8.53e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CAV1—stomach cancer	1.25e-05	8.47e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—APOA1—stomach cancer	1.25e-05	8.45e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—stomach cancer	1.24e-05	8.36e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPP2R1A—stomach cancer	1.24e-05	8.35e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO1—stomach cancer	1.24e-05	8.34e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPP2R1A—stomach cancer	1.23e-05	8.33e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PDHA1—stomach cancer	1.23e-05	8.32e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ECHS1—stomach cancer	1.23e-05	8.32e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMOX1—stomach cancer	1.22e-05	8.25e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—stomach cancer	1.21e-05	8.19e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—stomach cancer	1.21e-05	8.17e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMOX1—stomach cancer	1.2e-05	8.08e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMOX1—stomach cancer	1.19e-05	8.06e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CAV1—stomach cancer	1.17e-05	7.88e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—APOA1—stomach cancer	1.17e-05	7.87e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TYMP—stomach cancer	1.16e-05	7.82e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FADS1—stomach cancer	1.16e-05	7.82e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.16e-05	7.8e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TYMS—stomach cancer	1.15e-05	7.78e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—stomach cancer	1.14e-05	7.69e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TYMS—stomach cancer	1.13e-05	7.62e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TYMS—stomach cancer	1.13e-05	7.6e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—stomach cancer	1.12e-05	7.53e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—stomach cancer	1.11e-05	7.51e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—stomach cancer	1.11e-05	7.46e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PPARG—stomach cancer	1.1e-05	7.45e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CD44—stomach cancer	1.1e-05	7.4e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SREBF2—stomach cancer	1.08e-05	7.32e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—RORA—stomach cancer	1.07e-05	7.23e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ERCC2—stomach cancer	1.07e-05	7.23e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ERCC2—stomach cancer	1.05e-05	7.08e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ERCC2—stomach cancer	1.05e-05	7.06e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PPARG—stomach cancer	1.03e-05	6.93e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MTHFR—stomach cancer	1.01e-05	6.79e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDOB—stomach cancer	1e-05	6.78e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—stomach cancer	9.92e-06	6.7e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MTHFR—stomach cancer	9.85e-06	6.65e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MTHFR—stomach cancer	9.83e-06	6.64e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NOS3—stomach cancer	9.49e-06	6.41e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALOX5—stomach cancer	9.34e-06	6.3e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPP2R1A—stomach cancer	9.32e-06	6.29e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CAV1—stomach cancer	9.28e-06	6.27e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—APOA1—stomach cancer	9.26e-06	6.25e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—stomach cancer	9.23e-06	6.23e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—DPYD—stomach cancer	9.18e-06	6.2e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—stomach cancer	9.14e-06	6.17e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CAV1—stomach cancer	9.09e-06	6.14e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CAV1—stomach cancer	9.07e-06	6.12e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—APOA1—stomach cancer	9.07e-06	6.12e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—APOA1—stomach cancer	9.05e-06	6.11e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMOX1—stomach cancer	9.01e-06	6.08e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NOS3—stomach cancer	8.83e-06	5.96e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—stomach cancer	8.68e-06	5.86e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TYMS—stomach cancer	8.49e-06	5.73e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—stomach cancer	8.4e-06	5.67e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PPARG—stomach cancer	8.16e-06	5.51e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTT1—stomach cancer	8.12e-06	5.48e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—stomach cancer	8.08e-06	5.45e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2A6—stomach cancer	8.03e-06	5.42e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PPARG—stomach cancer	7.99e-06	5.39e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PPARG—stomach cancer	7.97e-06	5.38e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ERCC2—stomach cancer	7.89e-06	5.33e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKR1C3—stomach cancer	7.81e-06	5.27e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO1—stomach cancer	7.61e-06	5.14e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MTHFR—stomach cancer	7.42e-06	5.01e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—stomach cancer	7.34e-06	4.95e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—stomach cancer	7.19e-06	4.85e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—stomach cancer	7.17e-06	4.84e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NOS3—stomach cancer	7.02e-06	4.74e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NOS3—stomach cancer	6.87e-06	4.64e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NOS3—stomach cancer	6.86e-06	4.63e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CAV1—stomach cancer	6.84e-06	4.62e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—APOA1—stomach cancer	6.83e-06	4.61e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CD44—stomach cancer	6.75e-06	4.56e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—stomach cancer	6.42e-06	4.33e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—stomach cancer	6.29e-06	4.24e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—stomach cancer	6.27e-06	4.24e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PPARG—stomach cancer	6.02e-06	4.06e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPP2R1A—stomach cancer	5.74e-06	3.87e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—stomach cancer	5.63e-06	3.8e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMOX1—stomach cancer	5.55e-06	3.75e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—stomach cancer	5.41e-06	3.65e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—stomach cancer	5.34e-06	3.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TYMS—stomach cancer	5.23e-06	3.53e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NOS3—stomach cancer	5.18e-06	3.49e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—stomach cancer	5.17e-06	3.49e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—stomach cancer	4.97e-06	3.35e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ERCC2—stomach cancer	4.86e-06	3.28e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—stomach cancer	4.73e-06	3.2e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTHFR—stomach cancer	4.57e-06	3.09e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CAV1—stomach cancer	4.22e-06	2.85e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—APOA1—stomach cancer	4.21e-06	2.84e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—stomach cancer	3.95e-06	2.67e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—stomach cancer	3.87e-06	2.61e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—stomach cancer	3.86e-06	2.61e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARG—stomach cancer	3.71e-06	2.5e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—stomach cancer	3.33e-06	2.25e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NOS3—stomach cancer	3.19e-06	2.15e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—stomach cancer	2.92e-06	1.97e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—stomach cancer	2.91e-06	1.97e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.79e-06	1.21e-05	CbGpPWpGaD
